Pages that link to "Q33434238"
Jump to navigation
Jump to search
The following pages link to Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial (Q33434238):
Displaying 50 items.
- Therapeutic Approach to Adult Fibrotic Lung Diseases (Q26741569) (← links)
- Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis (Q33602730) (← links)
- Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience (Q33727800) (← links)
- Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease (Q37547111) (← links)
- Recent advances in connective tissue disease related interstitial lung disease (Q38678939) (← links)
- Lung Transplantation in Patients With Systemic Sclerosis (Q38733776) (← links)
- Recent advances in managing systemic sclerosis (Q38759138) (← links)
- Interstitial lung disease in systemic sclerosis: current and future treatment (Q38773637) (← links)
- Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies (Q38936954) (← links)
- Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). (Q38966586) (← links)
- Hypomyopathic dermatomyositis associated with interstitial lung disease and good response to mycophenolate mofetil: case-based review. (Q39147131) (← links)
- Interstital lung disease in ANCA vasculitis (Q39289311) (← links)
- Lung Manifestations in the Rheumatic Diseases (Q39335156) (← links)
- Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis. (Q40487999) (← links)
- Scleroderma-related interstitial lung disease (Q41105228) (← links)
- Use of Patterned Collagen Coated Slides to Study Normal and Scleroderma Lung Fibroblast Migration. (Q42090906) (← links)
- Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate). (Q42698900) (← links)
- Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II). (Q46255484) (← links)
- Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II. (Q46662148) (← links)
- Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma (Q47180993) (← links)
- Cyclophosphamide for connective tissue disease-associated interstitial lung disease (Q47216089) (← links)
- Wildflowers abundant in the garden of systemic sclerosis research, while hopeful exotics will one day bloom (Q47562171) (← links)
- AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease (Q47563113) (← links)
- Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II. (Q47599091) (← links)
- Anti-fibrotic nintedanib-a new opportunity for systemic sclerosis patients? (Q47607468) (← links)
- Determinants of mortality in systemic sclerosis: a focused review (Q47633128) (← links)
- Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group (Q49166002) (← links)
- Trial methodology in scleroderma: Avoiding a shot in the dark (Q49384975) (← links)
- Interstitial lung disease points to consider for clinical trials in systemic sclerosis. (Q49384982) (← links)
- Mycophenolate mofetil treatment of systemic sclerosis reduces myeloid cell numbers and attenuates the inflammatory gene signature in skin (Q49391534) (← links)
- Advocating for early interstitial lung disease detection in mixed connective tissue disease (Q49608149) (← links)
- Screening High Resolution Computed Tomography of the Chest to Detect Interstitial Lung Disease in Systemic Sclerosis: A Global Survey of Rheumatologists. (Q50095406) (← links)
- Clinically amyopathic dermatomyositis associated with anti-MDA5 antibody (Q50187621) (← links)
- Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post Hoc Analyses From Two Randomized Placebo-Controlled Trials (Q50623134) (← links)
- Evaluation and management approaches for scleroderma lung disease. (Q52939870) (← links)
- Lung Involvements in Rheumatic Diseases: Update on the Epidemiology, Pathogenesis, Clinical Features, and Treatment. (Q55361229) (← links)
- Systemic scleroderma-related interstitial pneumonia associated with borderline pulmonary arterial hypertension. (Q55546575) (← links)
- The British Society for Rheumatology guideline for the management of adults with primary Sjögren’s Syndrome (Q55970269) (← links)
- Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients (Q56893060) (← links)
- [Pulmonary fibrosis in rheumatic diseases] (Q56959250) (← links)
- Interstitial Pneumonia with Autoimmune Features: An emerging challenge at the intersection of rheumatology and pulmonology (Q57174251) (← links)
- [What rheumatologists can learn from pneumologists] (Q57176235) (← links)
- New insights into the genetics and epigenetics of systemic sclerosis (Q57285544) (← links)
- Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis (Q58553753) (← links)
- Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts (Q58574606) (← links)
- Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial (Q58764607) (← links)
- Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study (Q60923298) (← links)
- Interstitial lung disease associated with systemic sclerosis (SSc-ILD) (Q61446617) (← links)
- Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II) (Q61447467) (← links)
- Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors (Q61449497) (← links)